- Technology/Device
- Assessment of Insulin Secretion and Insulin Resistance in Human
-
So Young Park, Jean-François Gautier, Suk Chon
-
Diabetes Metab J. 2021;45(5):641-654. Published online September 30, 2021
-
DOI: https://doi.org/10.4093/dmj.2021.0220
-
-
20,321
View
-
1,169
Download
-
96
Web of Science
-
23
Crossref
-
Graphical Abstract
Abstract
PDF PubReader ePub

- The impaired insulin secretion and increased insulin resistance (or decreased insulin sensitivity) play a major role in the pathogenesis of all types of diabetes mellitus (DM). It is very important to assess the pancreatic β-cell function and insulin resistance/ sensitivity to determine the type of DM and to plan an optimal management and prevention strategy for DM. So far, various methods and indices have been developed to assess the β-cell function and insulin resistance/sensitivity based on static, dynamic test and calculation of their results. In fact, since the metabolism of glucose and insulin is made through a complex process related with various stimuli in several tissues, it is difficult to fully reflect the real physiology. In order to solve the theoretical and practical difficulties, research on new index is still in progress. Also, it is important to select the appropriate method and index for the purpose of use and clinical situation. This review summarized a variety of traditional methods and indices to evaluate pancreatic β-cell function and insulin resistance/sensitivity and introduced novel indices.
-
Citations
Citations to this article as recorded by 
- Polyphenol-Rich Extract of Fermented Chili Pepper Alleviates Insulin Resistance in HepG2 Cells via Regulating INSR, PTP1B, PPAR-γ, and AMPK Pathways
Tao Wang, Meiqi Li, Shengbao Cai, Linyan Zhou, Xiaosong Hu, Junjie Yi Fermentation.2023; 9(2): 84. CrossRef - 2,3-Dihydrosorbicillin and chrysopanol stimulate insulin secretion in INS-1 cells
Dahae Lee, Jaekyung Kim, Sungyoul Choi, Jinwon Choi, Jin Woo Lee, Ki Sung Kang, Sang Hee Shim Bioorganic & Medicinal Chemistry Letters.2023; 83: 129186. CrossRef - Insulin: A connection between pancreatic β cells and the hypothalamus
Brenda De la Cruz Concepción, Yaccil Adilene Flores Cortez, Martha Isela Barragán Bonilla, Juan Miguel Mendoza Bello, Monica Espinoza Rojo World Journal of Diabetes.2023; 14(2): 76. CrossRef - The Metabolic Score for Insulin Resistance (METS-IR) Predicts Cardiovascular Disease and Its Subtypes in Patients with Hypertension and Obstructive Sleep Apnea
Wenbo Yang, Xintian Cai, Junli Hu, Wen Wen, Heizhati Mulalibieke, Xiaoguang Yao, Ling Yao, Qing Zhu, Jing Hong, Qin Luo, Shasha Liu, Nanfang Li Clinical Epidemiology.2023; Volume 15: 177. CrossRef - Association between dietary patterns and biomarkers in connection with diabetes mellitus in adolescents: A systematic review
Bernardo Paz Barboza, Camila Tureck, Liliana Paula Bricarello, Mariane de Almeida Alves, Anabelle Retondario, Amanda de Moura Souza, Ricardo Fernandes, Francisco de Assis Guedes de Vasconcelos Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(4): 685. CrossRef - PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content
Ákos Nádasdi, Viktor Gál, Tamás Masszi, Anikó Somogyi, Gábor Firneisz Cardiovascular Diabetology.2023;[Epub] CrossRef - Ethnic Variability in Glucose and Insulin Response to Rice Among Healthy Overweight Adults: A Randomized Cross-Over Study
Amena Sadiya, Vidya Jakapure, Vijay Kumar Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 993. CrossRef - Familial partial lipodystrophy type 2 and obesity, two adipose tissue pathologies with different inflammatory profiles
Guillaume Treiber, Marie-Paule Gonthier, Alice Guilleux, Samir Medjane, Oriane Bonfanti, Muriel Cogne, Olivier Meilhac, Estelle Nobecourt Diabetology & Metabolic Syndrome.2023;[Epub] CrossRef - Discriminant Model for Insulin Resistance in Type 2 Diabetic Patients
Erislandis López-Galán, Rafael Barrio-Deler, Manuel Alejandro Fernández-Fernández, Yaquelin Del Toro-Delgado, Isaac Enrique Peñuela-Puente, Miguel Enrique Sánchez-Hechavarría, Mario Eugenio Muñoz-Bustos, Gustavo Alejandro Muñoz-Bustos Medicina.2023; 59(5): 839. CrossRef - Mechanisms of Oxidative Stress in Metabolic Syndrome
Sepiso K. Masenga, Lombe S. Kabwe, Martin Chakulya, Annet Kirabo International Journal of Molecular Sciences.2023; 24(9): 7898. CrossRef - Estimated Glucose Disposal Rate Predicts Renal Progression in Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Juan Peng, Aimei Li, Liangqingqing Yin, Qi Yang, Jinting Pan, Bin Yi Journal of the Endocrine Society.2023;[Epub] CrossRef - Transfer RNA Mutation Associated with Type 2 Diabetes Mellitus
Fanny Rizki Rahmadanthi, Iman Permana Maksum Biology.2023; 12(6): 871. CrossRef - Honokiol improves endothelial function in type 2 diabetic rats via alleviating oxidative stress and insulin resistance
An He, Huilin Yu, Yu Hu, Huiling Chen, Xiang Li, Jian Shen, Rongjuan Zhuang, Yi Chen, Bryan Richard Sasmita, Minghao Luo, Dingyi Lv Biochemical and Biophysical Research Communications.2022; 600: 109. CrossRef - Relationship of Vitamin A and Thyroid Function in Individuals With Obesity and After Laparoscopic Sleeve Gastrectomy
Bingwei Ma, Peng Yang, Jingyang Gao, Lei Du, Chunjun Sheng, Taofeek Usman, Xingchun Wang, Shen Qu Frontiers in Nutrition.2022;[Epub] CrossRef - Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record–Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial
Eun Young Lee, Seon-Ah Cha, Jae-Seung Yun, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Min Kyung Hyun, Seung-Hyun Ko Journal of Medical Internet Research.2022; 24(7): e37430. CrossRef - Acyclovir alleviates insulin resistance via activating PKM1 in diabetic mice
Zhuozhou Hu, Jing Zhou, Liang Han, Xiangxiang Li, Chun Li, Tongyu Wu, Jingjing Liu, Wenyang Zhao, Jia Kang, Xinping Chen Life Sciences.2022; 304: 120725. CrossRef - Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire
Tomoki Uchida, Takeshi Kanamori, Takanori Teramoto, Yuji Nonaka, Hiroki Tanaka, Satoshi Nakamura, Norihito Murayama, Rajesh Kaluri Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef - Elevated triglyceride-glucose (TyG) index predicts impaired islet β-cell function: A hospital-based cross-sectional study
Zi Chen, Jie Wen Frontiers in Endocrinology.2022;[Epub] CrossRef - Maternal Glycaemic and Insulinemic Status and Newborn DNA Methylation: Findings in Women With Overweight and Obesity
Marion Lecorguillé, Fionnuala M McAuliffe, Patrick J Twomey, Karien Viljoen, John Mehegan, Cecily C Kelleher, Matthew Suderman, Catherine M Phillips The Journal of Clinical Endocrinology & Metabolism.2022; 108(1): 85. CrossRef - Acanthosis Nigricans: Pointer of Endocrine Entities
Andreea-Maria Radu, Mara Carsote, Mihai Cristian Dumitrascu, Florica Sandru Diagnostics.2022; 12(10): 2519. CrossRef - Relationship between Insulin Resistance Risk Scales and Non-Alcoholic Fatty Liver Disease and Liver Fibrosis Scales in 219,477 Spanish Workers
José Ignacio Ramírez-Manent, Emilio Martínez-Almoyna, Carlos López, Carla Busquets-Cortés, Hilda González San Miguel, Ángel Arturo López-González Metabolites.2022; 12(11): 1093. CrossRef - Investigation of Insulin Secretion in Glucose Tolerance Test by the Intake of Novel Imeglimin (Twymeeg)
Hiroshi BANDO, Hiroko OGAWA, Hirohisa URASAKI, Shinji NAGAHIRO, Hiroko URASAKI, Miwako NAKANISHI, Osami WATANABE Asploro Journal of Biomedical and Clinical Case Reports.2022; 5(3): 113. CrossRef - Evaluation and Screening of Hypoglycemic Activity of Total Ginsenosides GBE-5 Fraction From Panax Ginseng Berry Based on UHPLC–MS Metabolomics
Heyu Wang, Yu Tong, Anqi Wang, Ying Li, Bofan Lu, Hui Li, Lili Jiao, Wei Wu Frontiers in Nutrition.2022;[Epub] CrossRef
- Islet Studies and Transplantation
- An Update on the Effect of Incretin-Based Therapies on β-Cell Function and Mass
-
Suk Chon, Jean-François Gautier
-
Diabetes Metab J. 2016;40(2):99-114. Published online April 25, 2016
-
DOI: https://doi.org/10.4093/dmj.2016.40.2.99
-
-
6,534
View
-
134
Download
-
45
Web of Science
-
43
Crossref
-
Abstract
PDF PubReader
Type 2 diabetes mellitus (T2DM) is a multifactorial disease with a complex and progressive pathogenesis. The two primary mechanisms of T2DM pathogenesis are pancreatic β-cell dysfunction and insulin resistance. Pancreatic β-cell dysfunction is recognized to be a prerequisite for the development of T2DM. Therapeutic modalities that improve β-cell function are considered critical to T2DM management; however, blood glucose control remains a challenge for many patients due to suboptimal treatment efficacy and the progressive nature of T2DM. Incretin-based therapies are now the most frequently prescribed antidiabetic drugs in Korea. Incretin-based therapies are a favorable class of drugs due to their ability to reduce blood glucose by targeting the incretin hormone system and, most notably, their potential to improve pancreatic β-cell function. This review outlines the current understanding of the incretin hormone system in T2DM and summarizes recent updates on the effect of incretin-based therapies on β-cell function and β-cell mass in animals and humans.
-
Citations
Citations to this article as recorded by 
- GLP-1 Analogue-Loaded Glucose-Responsive Nanoparticles as Allies of Stem Cell Therapies for the Treatment of Type I Diabetes
Joana Moreira Marques, Rute Nunes, Ana Margarida Carvalho, Helena Florindo, Domingos Ferreira, Bruno Sarmento ACS Pharmacology & Translational Science.2024; 7(5): 1650. CrossRef - Bisphenol a accelerates the glucolipotoxicity-induced dysfunction of rat insulinoma cell lines: An implication for a potential risk of environmental bisphenol a exposure for individuals susceptible to type 2 diabetes
Chengmeng Huang, Xiaolin Chen, Zedong Ouyang, Lingxue Meng, Jian Liu, Qihua Pang, Ruifang Fan Toxicology in Vitro.2024; 99: 105866. CrossRef - Harnessing gut cells for functional insulin production: Strategies and challenges
Kelvin Baafi, John C. March Biotechnology Notes.2023; 4: 7. CrossRef - Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho Endocrinology and Metabolism.2023; 38(1): 1. CrossRef - Weight loss maintenance with exercise and liraglutide improves glucose tolerance, glucagon response, and beta cell function
Simon B. K. Jensen, Christian R. Juhl, Charlotte Janus, Julie R. Lundgren, Christoffer Martinussen, Christoffer Wiingaard, Cecilie Knudsen, Ruth Frikke‐Schmidt, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad, Signe S. Torekov Obesity.2023; 31(4): 977. CrossRef - How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk
Inah Camaya, Bronwyn O’Brien, Sheila Donnelly Frontiers in Endocrinology.2023;[Epub] CrossRef - An Imbalance of Pathophysiologic Factors in Late Postprandial Hypoglycemia Post Bariatric Surgery: A Narrative Review
Marah Alsayed Hasan, Stanley Schwartz, Victoria McKenna, Richard Ing Obesity Surgery.2023; 33(9): 2927. CrossRef - Therapeutic Dilemma in Personalized Medicine
Ehab S. EL Desoky Current Reviews in Clinical and Experimental Pharmacology.2022; 17(2): 94. CrossRef - Lessons from neonatal β-cell epigenomic for diabetes prevention and treatment
Amar Abderrahmani, Cécile Jacovetti, Romano Regazzi Trends in Endocrinology & Metabolism.2022; 33(6): 378. CrossRef - Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin Diabetes, Obesity and Metabolism.2022; 24(12): 2353. CrossRef - A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes
Chih-Yuan Wang, Kuo-Chin Huang, Chia-Wen Lu, Chih-Hsun Chu, Chien-Ning Huang, Harn-Shen Chen, I-Te Lee, Jung-Fu Chen, Ching-Chu Chen, Chung-Sen Chen, Chang-Hsun Hsieh, Kai-Jen Tien, Hung-Yu Chien, Yu-Yao Huang, Jui-Pao Hsu, Guang-Tzuu Shane, Ai-Ching Chan The Journal of Clinical Endocrinology & Metabolism.2022; 107(10): e4063. CrossRef - Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
Tao Tao, Yi Zhang, Yu-Chen Zhu, Jia-Rong Fu, Yu-Ying Wang, Jie Cai, Jing-Yu Ma, Yu Xu, Yi-Ning Gao, Yun Sun, WuQiang Fan, Wei Liu The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1420. CrossRef - The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study
Tuccinardi Dario, Giorgino Riccardo, Pieralice Silvia, Watanabe Mikiko, Maggi Daria, Palermo Andrea, Defeudis Giuseppe, Fioriti Elvira, Pozzilli Paolo, Manfrini Silvia Acta Diabetologica.2021; 58(4): 411. CrossRef - Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy
E. V. Biryukova, I. A. Morozova, S. V. Rodionova Meditsinskiy sovet = Medical Council.2021; (21): 160. CrossRef - Emerging Role of Caveolin-1 in GLP-1 Action
Alessandra Puddu, Davide Maggi Frontiers in Endocrinology.2021;[Epub] CrossRef - Improvements in HOMA indices and pancreatic endocrinal tissues in type 2-diabetic rats by DPP-4 inhibition and antioxidant potential of an ethanol fruit extract of Withania coagulans
Heera Ram, Pramod Kumar, Ashok Purohit, Priya Kashyap, Suresh Kumar, Shivani Kumar, Garima Singh, Abdulaziz A. Alqarawi, Abeer Hashem, Elsayed Fathi Abd-Allah, Al-Bandari Fahad Al-Arjani, Bhim Pratap Singh Nutrition & Metabolism.2021;[Epub] CrossRef -
Chop
/
Ddit3
depletion in β cells alleviates ER stress and corrects hepatic steatosis in mice
Jing Yong, Vishal S. Parekh, Shannon M. Reilly, Jonamani Nayak, Zhouji Chen, Cynthia Lebeaupin, Insook Jang, Jiangwei Zhang, Thazha P. Prakash, Hong Sun, Sue Murray, Shuling Guo, Julio E. Ayala, Leslie S. Satin, Alan R. Saltiel, Randal J. Kaufman Science Translational Medicine.2021;[Epub] CrossRef - Assessment of Insulin Secretion and Insulin Resistance in Human
So Young Park, Jean-François Gautier, Suk Chon Diabetes & Metabolism Journal.2021; 45(5): 641. CrossRef - Targeted pharmacological therapy restores β-cell function for diabetes remission
Stephan Sachs, Aimée Bastidas-Ponce, Sophie Tritschler, Mostafa Bakhti, Anika Böttcher, Miguel A. Sánchez-Garrido, Marta Tarquis-Medina, Maximilian Kleinert, Katrin Fischer, Sigrid Jall, Alexandra Harger, Erik Bader, Sara Roscioni, Siegfried Ussar, Annett Nature Metabolism.2020; 2(2): 192. CrossRef - The Relationship Between Timing of Initiation on a Glucagon-like Peptide-1 Receptor Agonist and Glycosylated Hemoglobin Values Among Patients With Type 2 Diabetes
Kristina S. Boye, Reema Mody, Maureen J. Lage, Raleigh E. Malik Clinical Therapeutics.2020; 42(9): 1812. CrossRef - Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study
Valentina K. Bayrasheva, Ivan Y. Pchelin, Vladimir A. Dobronravov, Alina Yu. Babenko, Svetlana G. Chefu, Ivan S. Shatalov, Volha N. Vasilkova, Natalia V. Hudiakova, Alexandra N. Ivanova, Pavel A. Andoskin, Elena N. Grineva Archives of Endocrinology and Metabolism.2020;[Epub] CrossRef - A Phenotypic Screen Identifies Calcium Overload as a Key Mechanism of β-Cell Glucolipotoxicity
Jennifer Vogel, Jianning Yin, Liansheng Su, Sharon X. Wang, Richard Zessis, Sena Fowler, Chun-Hao Chiu, Aaron C. Wilson, Amy Chen, Frederic Zecri, Gordon Turner, Thomas M. Smith, Brian DeChristopher, Heming Xing, Deborah M. Rothman, Xinming Cai, Alina Ber Diabetes.2020; 69(5): 1032. CrossRef - Neuropeptide 26RFa (QRFP) is a key regulator of glucose homeostasis and its activity is markedly altered in obese/hyperglycemic mice
Gaëtan Prévost, Arnaud Arabo, Marie-Anne Le Solliec, Justine Bons, Marie Picot, Julie Maucotel, Hind Berrahmoune, Mouna El Mehdi, Saloua Cherifi, Alexandre Benani, Emmanuelle Nédélec, Moïse Coëffier, Jérôme Leprince, Anneli Nordqvist, Valéry Brunel, Pierr American Journal of Physiology-Endocrinology and Metabolism.2019; 317(1): E147. CrossRef - Gastrin analogue administration adds no significant glycaemic benefit to a glucagon‐like peptide‐1 receptor agonist acutely or after washout of both analogues
Krister Bokvist, Ying Ding, William H. Landschulz, Vikram Sinha, Aleksandra Pastrak, Ruth M. Belin Diabetes, Obesity and Metabolism.2019; 21(7): 1606. CrossRef - Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1
Lie-Chwen Lin, Lin-Chien Lee, Cheng Huang, Chiung-Tong Chen, Jen-Shin Song, Young-Ji Shiao, Hui-Kang Liu Phytomedicine.2019; 62: 152946. CrossRef - The future of new drugs for diabetes management
Clifford J. Bailey, Caroline Day Diabetes Research and Clinical Practice.2019; 155: 107785. CrossRef - Compact fluidic system for functional assessment of pancreatic islets
Takeshi Hori, Kei Yamane, Takayuki Anazawa, Osamu Kurosawa, Hiroo Iwata Biomedical Microdevices.2019;[Epub] CrossRef - Pharmacokinetics of Exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and Bydureon
Yazhou Li, Kelli L. Vaughan, David Tweedie, Jin Jung, Hee Kyung Kim, Ho-Il Choi, Dong Seok Kim, Julie A. Mattison, Nigel H. Greig Scientific Reports.2019;[Epub] CrossRef - Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury
Miaad Bader, Yazhou Li, Daniela Lecca, Vardit Rubovitch, David Tweedie, Elliot Glotfelty, Lital Rachmany, Hee Kyung Kim, Ho-Il Choi, Barry J. Hoffer, Chaim G. Pick, Nigel H. Greig, Dong Seok Kim Neurobiology of Disease.2019; 124: 439. CrossRef - Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential
N.M. Pathak, V. Pathak, V.A. Gault, S. McClean, N. Irwin, P.R. Flatt Biochemical Pharmacology.2018; 155: 264. CrossRef - Human EndoC-βH1 β-cells form pseudoislets with improved glucose sensitivity and enhanced GLP-1 signaling in the presence of islet-derived endothelial cells
Michael G. Spelios, Lauren A. Afinowicz, Regine C. Tipon, Eitan M. Akirav American Journal of Physiology-Endocrinology and Metabolism.2018; 314(5): E512. CrossRef - Vildagliptin: ten years in the service for type 2 diabetes mellitus patients. The journey of discovery, innovation and success in clinical practice
Tatiana Yu. Demidova Problems of Endocrinology.2018; 64(5): 336. CrossRef - Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
Paola Simeone, Rossella Liani, Romina Tripaldi, Augusto Di Castelnuovo, Maria Teresa Guagnano, Armando Tartaro, Riccardo C. Bonadonna, Virginia Federico, Francesco Cipollone, Agostino Consoli, Francesca Santilli Nutrients.2018; 10(12): 1872. CrossRef - Nutrient regulation of β-cell function: what do islet cell/animal studies tell us?
R Carlessi, K N Keane, C Mamotte, P Newsholme European Journal of Clinical Nutrition.2017; 71(7): 890. CrossRef - Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
You-Cheol Hwang, Ari Kim, Euna Jo, Yeoree Yang, Jae-Hyoung Cho, Byung-Wan Lee BMC Endocrine Disorders.2017;[Epub] CrossRef - Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
Sang‐Mo Hong, Cheol‐Young Park, Dong‐Min Hwang, Kyung Ah Han, Chang Beom Lee, Choon Hee Chung, Kun‐Ho Yoon, Ji‐Oh Mok, Kyong Soo Park, Sung‐Woo Park Diabetes, Obesity and Metabolism.2017; 19(5): 654. CrossRef - The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)
Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, Kota Ono, Hiroshi Nomoto, Aika Miya, Chiho Yamamoto, Atsushi Inoue, Kenichi Tsuchida, Naoki Manda, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura, Tatsuya Atsumi Cardiovascular Diabetology.2017;[Epub] CrossRef - Recent Advances in Effect‐directed Enzyme Assays based on Thin‐layer Chromatography
Sarah Bräm, Evelyn Wolfram Phytochemical Analysis.2017; 28(2): 74. CrossRef - Efficacy and safety of gemigliptin, a dipeptidyl peptidase‐4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24‐week, multicentre, randomized, double‐blind, placebo‐
Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, Joo Young Nam, Kyu Jeung Ahn, Tae Keun Oh, Hyoung Woo Lee, Dae Ho Lee, Jaetaek Kim, Choon Hee Chung, Tae Sun Park, Byung Joon Kim, Seok Won Park, Hyeong Kyu Park, Kwang Jae Lee, Sang‐Wook Kim, Jeong Hyun Park, Kwa Diabetes, Obesity and Metabolism.2017; 19(5): 635. CrossRef - Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim The Korean Journal of Internal Medicine.2017; 32(6): 947. CrossRef - Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim Diabetes & Metabolism Journal.2017; 41(5): 337. CrossRef - DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
Eun Ju Bae Archives of Pharmacal Research.2016; 39(8): 1114. CrossRef - Liraglutide Enhances the Efficacy of Human Mesenchymal Stem Cells in Preserving Islet ß-cell Function in Severe Non-obese Diabetic Mice
Li-rong Li, Jing Lu, Xiao-lei Jia, Hui Hui, Jie Zhang, Ying Liu, Wei-juan Cui, Qian-yue Xu, Da-long Zhu Molecular Medicine.2016; 22(1): 800. CrossRef
|